The presence of high mobility group box-1 and soluble receptor for advanced glycation end-products in juvenile idiopathic arthritis and juvenile systemic lupus erythematosus

BACKGROUND: The involvement of high mobility group box-1 (HMGB1) in various inflammatory and autoimmune diseases has been documented but clinical trials on the contribution of this pro-inflammatory alarmin in children with juvenile idiopathic arthritis (JIA) and systemic lupus erythematosus (SLE) ar...

Descripción completa

Detalles Bibliográficos
Autores principales: Bobek, Dubravka, Grčević, Danka, Kovačić, Nataša, Lukić, Ivan Krešimir, Jelušić, Marija
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4267139/
https://www.ncbi.nlm.nih.gov/pubmed/25516724
http://dx.doi.org/10.1186/1546-0096-12-50

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4267139/
https://www.ncbi.nlm.nih.gov/pubmed/25516724
http://dx.doi.org/10.1186/1546-0096-12-50

Ejemplares similares